CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 144 Insider Sale of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes See Remarks gave up 733 shares (to pay taxes)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market sale See Remarks sold 40,000 shares at $5.43 ($217,244)
- 144 Insider Sale of Securities
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
Page 7 of 18 · 346 filings